Feasibility and accuracy of prostate cancer risk calculators in prediction of prostate cancer, extraprostatic extension as well as the risk of lymph nodes metastasis

被引:0
|
作者
Kulik, Kacper [1 ,2 ]
Brzoska, Rafal [1 ]
Mazurek, Ewelina [1 ]
Ostrowska, Magdalena [1 ]
Ostrowski, Adam [1 ]
Kowalski, Filip [1 ]
Wilamowski, Jacek [1 ]
Drewa, Tomasz [1 ]
Adamowicz, Jan [1 ]
Juszczak, Kajetan [1 ]
机构
[1] Nicolaus Copernicus Univ Torun, Dept Urol & Androl, Coll Med Bydgoszcz, Bydgoszcz, Poland
[2] Nicolaus Copernicus Univ Torun, Dept Urol & Androl, Coll Med Bydgoszcz, 13-15 Jagiellonska, PL-85094 Bydgoszcz, Poland
关键词
prostate cancer; nomograms; risk calculators; EXTERNAL VALIDATION; PATHOLOGICAL STAGE; UPDATED NOMOGRAM; CLINICAL STAGE; BIOPSY; DISSECTION; INVASION; DIAGNOSIS; ERSPC;
D O I
10.5173/ceju.2023.168
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction The aim of this article was to evaluate the accuracy of European Randomized study tor on predicting high-grade prostate cancer (HGPCa) and accuracy of Partin and Briganti nomograms on organ confined (OC) or extraprostatic cancer (EXP), seminal vesicles invasion (SVI) and risk of lymph nodes metastasis. Material and methods A cohort of 269 men aged between 44-84 years, who underwent radical prostatectomy was retrospectively analysed. Based on estimated calculator risk, patients were divided into risk groups: low (LR), medium (MR) and high (HR). Results obtained with calculators were compared to post-surgical final pathology outcome. Results In ERPSC4, the average risk for HGPC was LR = 5%, MR = 21%, and HR = 64%. In PCPT 2.0, the average risk for HG was: LR - 8%, MR - 14%, and HR - 30%. In the final results, HGPC was observed in: LR = 29%, MR = 67%, and HR = 81%. In Partin, LNI was estimated to occur in: LR = 1%, MR = 2%, and HR = 7.5% and in Briganti: LR = 1.8%, MR = 11.4%, and HR = 44.2% while finally it was found in: LR = 1.3%, MR = 0%, and HR = 11.6%. Conclusions ERPSC 4 and PCPT 2.0 corresponded well with each other as well as Partin and Briganti. ERPSC 4 was more accurate in predicting HGPC than PCPT 2.0. Partin was more accurate as for LNI than Briganti. In this study group a large underestimation was observed in reference to Gleason grade.
引用
收藏
页码:20 / 24
页数:5
相关论文
共 50 条
  • [1] Prediction of Extraprostatic Extension in Intermediate Risk Prostate Cancer: The Evolving Role of Endorectal MRI
    Pugh, T. J.
    Frank, S. J.
    Achim, M.
    Kuban, D. A.
    Lee, A. K.
    Choi, S.
    Nguyen, Q.
    Hoffman, K.
    McGuire, S. E.
    Swanson, D. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S398 - S398
  • [2] Risk stratification for positive lymph nodes in prostate cancer
    Pettus, Joseph A.
    Masterson, Timothy A.
    Abel, E. Jason
    Middleton, Richard G.
    Stephenson, Robert A.
    JOURNAL OF ENDOUROLOGY, 2008, 22 (05) : 1021 - 1025
  • [3] Prediction of prostate cancer in biopsy-naive men: Diagnostic accuracy and external validation of current prostate cancer risk calculators
    Israel, B.
    Van der Leest, M. M. G.
    Sedelaar, J. P. M.
    Barentsz, J. O.
    Hannink, G. J.
    EUROPEAN UROLOGY, 2021, 79 : S1431 - S1433
  • [4] Prediction of Prostate Cancer Risk: The Role of Prostate Volume and Digital Rectal Examination in the ERSPC Risk Calculators
    Roobol, Monique J.
    van Vugt, Heidi A.
    Loeb, Stacy
    Zhu, Xiaoye
    Bul, Meelan
    Bangma, Chris H.
    van Leenders, Arno G. L. J. H.
    Steyerberg, Ewout W.
    Schroder, Fritz H.
    EUROPEAN UROLOGY, 2012, 61 (03) : 577 - 583
  • [5] Comparation between IPCRC (Indonesian Prostate Cancer Risk Calculator) and Western Prostate Cancer Risk Calculators for predicting prostate cancer risk
    Abshari, F.
    Yuri, P.
    Satjakoesoemah, A. I.
    Abdullah, R. R.
    Akbar, M. I.
    Wangge, G.
    Mochtar, C. A.
    Umbas, R.
    Hamid, A. R. A. H.
    BJU INTERNATIONAL, 2016, 117 : 18 - 18
  • [6] A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI
    Mehralivand, Sherif
    Shih, Joanna H.
    Harmon, Stephanie
    Smith, Clayton
    Bloom, Jonathan
    Czarniecki, Marcin
    Gold, Samuel
    Hale, Graham
    Rayn, Kareem
    Merino, Maria J.
    Wood, Bradford J.
    Pinto, Peter A.
    Choyke, Peter L.
    Turkbey, Baris
    RADIOLOGY, 2019, 290 (03) : 709 - 719
  • [7] The Next Generation of Prostate Cancer Risk Calculators
    Hermanns, Thomas
    Poyet, Cedric
    EUROPEAN UROLOGY, 2017, 72 (06) : 897 - 898
  • [8] PROSTATE CANCER Rescreening policies and risk calculators
    Roobol, Monique J.
    NATURE REVIEWS UROLOGY, 2014, 11 (08) : 429 - 430
  • [9] COMPARISON OF VARIOUS RISK CALCULATORS FOR PROSTATE CANCER
    Roobol, Monique J.
    TUMOR BIOLOGY, 2010, 31 : S27 - S27
  • [10] Prostate Cancer - Extraprostatic extension as a risk factor only from ISUP grade 2
    Simon, Annika
    AKTUELLE UROLOGIE, 2024, 55 (06) : 500 - 500